Douglas S. Ingram
Board Member
Sarepta Therapeutics, Inc. (SRPT)Board Member
Relay Therapeutics, Inc. (RLAY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas S. Ingram
Douglas S. Ingram is recorded as Board Member at Sarepta Therapeutics, Inc. (SRPT) and Board Member at Relay Therapeutics, Inc. (RLAY). Sarepta Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Douglas S. Ingram resigned as membership on the Board of Directors of the Company, effective July 28, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed July 27, 2026 that Douglas S. Ingram retired as Chief Executive Officer, effective July 28, 2026. Sarepta Therapeutics, Inc. reported in an 8-K filed June 4, 2026 that Douglas S. Ingram was appointed director, effective June 4, 2026. The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $7,840,666 for Douglas S. Ingram in fiscal 2025, including a base salary of $1,171,425. Disclosed compensation is on record for 8 fiscal years.
“As of the Effective Date, Consultant has resigned from all officer and other positions with the Company and its affiliates, including his membership on the Board of Directors of the Company.”
“Consultant is retiring from his employment with the Company as its Chief Executive Officer ("Retirement") effective as of July 28, 2026 (the "Effective Date")”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-04–present
-
Current
2019-01-01–present
-
2026-06-04–2026-07-28
-
Start not stated–2026-07-28
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Relay Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Thomas Catinazzo CFO
- Claire Mazumdar Board Member
- Habib Dable Board Member
- Lonnel Coats Board Member
- Sekar Kathiresan, M.D. Board Member
Leadership on record at Sarepta Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Douglas Ingram CEO, Board Member
- Michael Severino, M.D. CEO, Board Member
- M. Kathleen Behrens Chairman
- Ryan H. Wong CFO
- Ian Estepan COO, Chief Accounting Officer
- Ian M. Estepan COO
- Cristin L. Rothfuss General Counsel
- Claude Nicaise Board Member
- Claude Nicaise, M.D. Board Member
- Deirdre Connelly Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sarepta Therapeutics, Inc. (SRPT) | Chief Executive Officer | $1,171,425 | $7,840,666 |
| 2024 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer | $846,902 | $1,978,086 |
| 2023 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer | $799,797 | $1,661,338 |
| 2022 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer | $740,025 | $124,938,694 |
| 2021 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer | $729,675 | $1,546,324 |
| 2020 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $669,250 | $1,291,947 |
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,387,072 |
| 2018 | Sarepta Therapeutics, Inc. (SRPT) | President and Chief Executive Officer ^^ | $650,000 | $1,433,872 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.